Rigel Pharmaceuticals Statistics
NASDAQ: RIGLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
47.99+1.88 (+4.08%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Rigel Pharmaceuticals by the numbers
Rigel Pharmaceuticals has a market capitalization of $896.4 million based on 18.68M shares outstanding. Its trailing P/E ratio is 2.8, and its forward P/E is 9.7. The stock trades 6.9% above its 50-day average and 31.2% above its 200-day average.
Average daily trading volume is 291.58K shares, or about $14.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RIGL valuation vs. peer median
| Metric | RIGL | Peer median | Difference |
|---|---|---|---|
| Market cap | $896.45M | $891.78M | +1% |
| Avg. volume | 291.58K | 929.04K | -69% |
Peer median across 8 companies: ANL, CYRX, MLTX, ALMS, JBIO, CRVS, ANRO, KURA.
Valuation
- Market cap
- $896.45M
- P/E (TTM)
- 2.84
- Forward P/E
- 9.72
- EPS (TTM)
- $16.88
- Shares outstanding
- 18.68M
Price and trading
- Previous close
- 46.11
- Open
- 45.64
- Day range
- 45.22 – 48.15
- 52-week range
- 24.95 – 52.24
- 52-week change
- +62.68%
- Beta
- —
- Volume
- 232.58K
- Average volume
- 291.58K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 896.45M
- Pe
- 2.84
- Forward Pe
- 9.72
- Eps
- 16.88
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 52.24
- Week52 Low
- 24.95
- Avg Volume
- 291.58K
- Shares Outstanding
- 18.68M
- Ma50
- 44.88
- Ma200
- 36.59
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -8.14%
- Pct From52w Low
- 92.34%